key: cord-0964880-reh30awd authors: Mohamed, Mohamed O.; Gale, Chris P.; Kontopantelis, Evangelos; Doran, Tim; de Belder, Mark; Asaria, Miqdad; Luscher, Thomas; Wu, Jianhua; Rashid, Muhammad; Stephenson, Courtney; Denwood, Tom; Roebuck, Chris; Deanfield, John; Mamas, Mamas A. title: Sex-differences in mortality rates and underlying conditions for COVID-19 deaths in England and Wales date: 2020-07-23 journal: Mayo Clin Proc DOI: 10.1016/j.mayocp.2020.07.009 sha: af77ee71b2290ffe9570ac95c1d31b6e99dbbb25 doc_id: 964880 cord_uid: reh30awd Abstract Background Limited national data exists on the prevalence and distribution of underlying conditions among COVID-19 deaths between sexes and across age groups.background Methods All adult (≥18 years) deaths recorded in England and Wales (1st March 2020 to 12th May 2020) were retrospectively analyzed. We compared 1) the prevalence of underlying health conditions between COVID and non-COVID related deaths during the COVID-19 pandemic and 2) the age-standardized mortality rate (ASMR) of COVID-19 compared with other primary causes of death, stratified by sex and age group. Results Of 144,279 adult deaths recorded during the study period, 36,438 (25.3%) were confirmed COVID cases. Women represented 43.2% (n=15,731) of COVID deaths compared to 51.9% (n=55,980) in non-COVID deaths. Overall, COVID deaths were younger non-COVID deaths (82 vs. 83 years). ASMR of COVID-19 was higher than all other common primary causes of death, across age groups and sexes, except for cancers in women between the ages of 30-79 years. A linear relationship was observed between ASMR and age amongst COVID-19 deaths, with persistently higher rates in men than women across all age groups. The most prevalent reported conditions were hypertension, dementia, chronic lung disease and diabetes, and these were higher amongst COVID deaths. Pre-existing ischemic heart disease was similar in COVID (11.4%) and non-COVID (12%) deaths.results Conclusions In a nationwide analysis, COVID-19 infection was associated with higher age-standardized mortality than other primary causes of death, except cancer in women of select age groups. COVID-19 mortality was persistently higher in men and increased with advanced age.conclusion More than 12 million patients worldwide have been infected with the severe acute respiratory syndrome coronavirus (SARS-CoV-2), resulting in the illness referred to as COVID-19. 1 The United Kingdom (UK) has the second highest recorded number of deaths in the world after the US, with 39,728 deaths recorded as of 6 th June 2020. 2 3 Age and comorbidities such as hypertension, diabetes and ischemic heart disease (IHD) are strong predictors of adverse outcomes and mortality in people infected with COVID-19. 4 5 6 Furthermore, differences in COVID-19 survival has been observed between sexes, with females shown to have better outcomes. Several hypotheses have been proposed as an explanation of the latter, including biological (genetic and hormonal) differences between sexes as well as lower burden of comorbidity in females. [4] [5] [6] [7] [8] Detailed data concerning underlying conditions is limited, with data from New York state reporting that 89.7% of fatalities attributed to COVID-19 had at least one comorbidity, most commonly hypertension, diabetes and hyperlipidemia. 9 In the UK 91% of COVID-19 deaths in March 2020 had at least one pre-existing condition, with ischemic heart disease the most common (14%). 10 There is inconclusive evidence, however, on how the distribution of underlying conditions varies by sex and age in those that have died from COVID-19. [11] [12] [13] Furthermore, it is unclear as to how the underlying conditions in COVID-19 deaths differ from those in similar age/sex groups that have died from non-COVID related causes. Therefore, we investigated the pre-existing conditions in adults (≥18 years) who had died from COVID-19 in England and Wales between 1 st March 2020 and 12 th May 2020, stratified by sex and age group, and compare this with patients whose death was not attributed to COVID-19. We compared the reported underlying acute and chronic conditions between patients with and without confirmed COVID-19 as the underlying primary contributory cause, stratified according to sex, and age band (18-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80-89 and ≥90 years). Age was not normally distributed and therefore summarized using median and interquartile range (IQR) and compared using the Kruskal-Wallis test. Categorical variables were summarized as percentages and analyzed using the chi squared (X 2 ) test or Fisher's exact test, where appropriate. Age-standardized mortality rates (ASMR), expressed as rates per 100,000 capita, were calculated for each age band based on the mid-2019 population census for England and Wales. 15 Statistical analyses were performed using Stata 16 MP (College Station, TX). This work was endorsed by the Scientific Advisory Group for Emergencies (SAGE), the body responsible for ensuring timely and coordinated scientific advice is made available to UK government decision makers. SAGE supports UK cross-government decisions in the Cabinet Office Briefing Room (COBR)) and by NHS England, which overseas commissioning decisions in the NHS, and NHS Improvement, which is responsible for overseeing quality of care in NHS hospitals. The majority of death were observed among people aged 80-89 years (COVID: 38.9%, non-COVID: 36.4%, Table 1 ). ASMR increased with age in both groups and were consistently higher for all age bands for non-COVID compared with COVID deaths. The ASMR was 61.4 per 100,000 population in the 60-69 age group for COVID deaths and 172.5 per 100,000 population for non-COVID deaths. The absolute number of COVID-19 deaths was higher for men than women throughout the study period (Figure 1) , with peak mortality observed between the 4 th and 20 th April 2020. The ASMR was approximately two-fold higher in men compared to women across all age groups for COVID-19 related deaths. (Table 1, Figure 2 ) A similar pattern was observed in the non-COVID group, albeit with less pronounced sex differences in ASMR. Overall, the most common cause of death in younger age groups (<60 years) was cancer, whereas the most common causes of death in older age groups (>80 years) were dementia, cancer and old age ( Table 2) . However, ASMR of COVID-19 was higher than all other primary causes of death for people without COVID-19 across all age groups and sexes, with the exception of cancer deaths for women aged years. The highest number of COVID-19 deaths was in London (total/male/female: 7,510, 4,519, 2,991). (Table S2, Figure S1 ) Approximately a third of individuals had no underlying chronic conditions in the non-COVID (29.9%) and COVID groups (31.8%), and close to one in ten patients with COVID-19 and non-COVID-19 deaths had three or more underlying conditions (10.4% vs. 9%). (Table 3, Figure 3 ) The rate of reported underlying chronic conditions was generally higher in COVID than non-COVID deaths, with the most prevalent reported conditions being hypertension (COVID vs. non-COVID: 19 .0% and 11.2%), dementia ( and diabetes (COVID vs. non-COVID: 15.2% vs. 8.1%). The rates of pre-existing IHD were similar in COVID (11.4%) and non-COVID (12%) deaths, although lower reported rates of cancers (7.8% vs. 23 .4%) were observed amongst patients with reported COVID deaths. ( England and Wales, is the first to demonstrate that the age standardized mortality rate of COVID is significantly higher than that of any other primary cause of death in non-COVID subjects throughout the same period. This finding was consistent across all age groups and in both sexes, with the exception of women between 30-79 years whose mortality from cancer was comparable to that from COVID. Our findings suggest that age-standardized mortality in men was almost double compared to that of women across all age groups, despite crude death rates suggesting a significantly higher proportion of women ≥90 years dying from COVID-19 compared with men. Our crude findings are consistent with reports in the US, which show 41.7% of female deaths were amongst those 85 years and older compared to only 23.9% in men, with higher mortality in younger male age groups compared to women. 17 Similarly, data on COVIDrelated deaths in Italy (n=31,096) demonstrates higher mortality in men than women across all age deciles except ≥90 years where mortality was higher than in women. 16 However, neither analyses provided an adjustment for age, which makes comparisons between sexes challenging. Differences in outcomes between sexes could be explained by the greater number of reported underlying conditions in men compared to women as demonstrated in our analysis. Another proposed hypothesis relates to the circulating level of angiotensin-converting enzyme 2 (ACE2), the main host cell receptor towards which SARS-CoV-2 has been shown to have significantly high affinity, which has been shown to be greater in men than women, and in adults compared to children. 28 5, 29 Furthermore, women are believed to have a better immune response against viral infections compared with men, primarily due to higher levels of estrogen, which is also believed to directly suppress viral replication. 7, 8, 13 The decline in levels of estrogen with advanced age, albeit with higher level in females throughout, could also explain the higher rate of mortality elder subjects. 6 Our analysis suggests that a small proportion of COVID-19 deaths experienced acute events such ACS, acute stroke and pulmonary embolism, and these were lower than in non-COVID deaths. It is difficult to compare these findings to other studies due to limited data on the acute conditions reported in COVID deaths from other countries, or whether there may have been an element of reporting bias, where acute events were reported as COVID deaths. Previous studies have suggested a high prevalence of certain comorbidities such as hypertension and ischemic heart disease in patients who died from COVID-19. 20 24, 25 30 However, these have been mostly limited by their small sample size or analysis of selected cohorts (e.g. intensive care admission only). In our analysis we find that a third of individuals who died had no underlying chronic conditions, but there were more chronic conditions in COVID than non-COVID deaths, with the most prevalent reported being hypertension, dementia, chronic lung disease and diabetes in both groups. Interestingly, we find that the prevalence of ischemic heart disease in COVID-19 related deaths is similar to that observed in non COVID-19 deaths, apart from in younger men (<60 years old) where paradoxically the prevalence is double that in patients that died non-COVID deaths. Reports from several studies have demonstrated a high prevalence of cardiovascular disease (CVD) in patients with COVID-19. 25 24 31 Although the underlying mechanisms are unclear, patients with CVD are more likely to develop severe COVIDinfection, which is attributed to multiple factors including advanced age, lower ACE2 levels and impaired immunity. 32 It is also possible that pharmacological treatment administered for COVID infection provokes fatal arrhythmias, to which CVD patients appear to be more susceptible. 33 In a meta-analysis of 1576 COVID-infected patients, the most prevalent comorbidities were hypertension (21.1%), diabetes (9.7%) and CVD (8.4%). Their analysis showed that the odds ratios (OR) of hypertension and CVD were significantly higher in patients with severe than non-severe COVID (OR 2.36 (95% confidence interval (CI): 1.46-3.83) and 3.42 (95% CI: 1.88-6.22), respectively). 34 However, these data may not hold true in patients who die from COVID, who may have greater baseline comorbidity. In a report from the Italian Instituto Superiore Di Sanita the prevalence of hypertension (68.3%) and ischemic heart disease (28.3%) was significantly higher in COVID deaths (n=31.096). 35 Differences between countries may reflect differences in reporting methods, or sociodemographic and genetic differences. Amongst COVID deaths, acute conditions were observed to be either similar between sexes (pulmonary embolism) or more prevalent in men (ACS and acute stroke). In terms of chronic conditions, women had higher rates of dementia, heart failure and chronic lung disease compared to men, whilst men had higher rates of pre-existing IHD, CKD, hypertension and diabetes. Notably, there was no difference in the rates of underlying cancer between sexes. Although the pattern of findings was consistent across age groups, certain differences in underlying conditions were noted. Pulmonary embolism was more frequently reported in <60 and 60-69 age deciles amongst COVID deaths, more so in men than women, whereas cancer rates were higher in younger age groups, especially in women compared to women: 15.6%), all of which are in line with our findings. 35 However, their report did not compare these conditions between age groups. The present findings have several important implications from a national and international perspective. Our comprehensive analysis adds to the body of literature on sex and age differences in patterns of death from a national perspective in a population with a high mortality rank. Furthermore, our report of underlying medical conditions in the overall population of COVID-19 deaths, as well as in both sexes, may help inform stakeholders' and governments' policies by identifying high-risk groups who could benefit from prolonged shielding, especially in the event of a second peak, and/or vaccination priority in the future. Although our study provides insights into the patterns of age and sex differences in COVID-19-related deaths and reported underlying medical conditions in a full nationwide cohort from England and Wales, there are a number of limitations. First, only conditions that were thought to contribute to the death are entered on the death certificate, rather than a list of all comorbid conditions that a patient may have. Our analysis therefore provides an overview of comorbid conditions that were judged by clinicians completing the death certificate to have contributed to death, without any external auditing, rather than a description of all prevalent comorbid conditions. Second, we did not have access to ethnic data, that may confound our analyses, particularly given that the mortality rate from COVID-19 in Black, Asian and minority ethnic people have been reported as up to three times greater. 36 In this nationwide analysis of deaths in England and Wales between 1 st March and 12 th May 2020, we demonstrate that the age-adjusted mortality of COVID-19 was higher than that of other primary causes of death across all age groups and in both sexes, with the exception of cancer mortality in women between 30-79 years, whose adjusted-mortality was higher than COVID-19. Our findings also suggest persistently higher age-adjusted mortality in men compared to women across all age groups throughout the study period. Our report of underlying medical conditions in the overall population of COVID-19 deaths, as well as in both sexes, may help inform stakeholders' and government body policies by identifying highrisk groups. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;94:91-95. Group C-S. Characteristics of COVID-19 patients dying in Italy: Istituto Superiore di Sanità; 2020. (ONS) OfNS. Coronavirus (COVID-19) related deaths by ethnic group, England and Wales: 2 March 2020 to 10 April 2020. Men Online Supplementary Material - Table S1 . List of ICD-10 CM diagnosis codes used in the study - Table S2 . Rates of COVID-19 deaths per county region according to sex - Table S3 . Characteristics and reported underlying conditions of deceased patients A) without and B) with COVID -19 according to sex and age group - Figure S1 . Distribution of Covid-19 deaths in England and Wales according to sex More than 12 million patients worldwide have been infected with the severe acute respiratory syndrome coronavirus (SARS-CoV-2), resulting in the illness referred to as COVID-19. 1 The United Kingdom (UK) has the second highest recorded number of deaths in the world after the US, with 39,728 deaths recorded as of 6 th June 2020. 2 3 Age and comorbidities such as hypertension, diabetes and ischemic heart disease (IHD) are strong predictors of adverse outcomes and mortality in people infected with COVID-19. 4 5 6 Furthermore, differences in COVID-19 survival has been observed between sexes, with females shown to have better outcomes. Several hypotheses have been proposed as an explanation of the latter, including biological (genetic and hormonal) differences between sexes as well as lower burden of comorbidity in females. [4] [5] [6] [7] [8] Detailed data concerning underlying conditions is limited, with data from New York state reporting that 89.7% of fatalities attributed to COVID-19 had at least one comorbidity, most commonly hypertension, diabetes and hyperlipidemia. 9 In the UK 91% of COVID-19 deaths in March 2020 had at least one pre-existing condition, with ischemic heart disease the most common (14%). 10 There is inconclusive evidence, however, on how the distribution of underlying conditions varies by sex and age in those that have died from COVID-19. [11] [12] [13] Furthermore, it is unclear as to how the underlying conditions in COVID-19 deaths differ from those in similar age/sex groups that have died from non-COVID related causes. Therefore, we investigated the pre-existing conditions in adults (≥18 years) who had died from COVID-19 in England and Wales between 1 st March 2020 and 12 th May 2020, stratified by sex and age group, and compare this with patients whose death was not attributed to COVID-19. This cross-sectional study included records of all adult (aged ≥18 years) deaths between 1 st March 2020 and 12 th May 2020 in England and Wales were collected from the Office for National Statistics (ONS) Civil Registrations of Death dataset and stratified according to COVID-19 status. 2 Children and adolescents aged below 18 years were excluded for the purpose of this analysis since their susceptibility to death from COVID-19 is significantly lower than adults, and the pattern of their causes of death vary to those in adults. 14 Supplementary Table S1 . We compared the reported underlying acute and chronic conditions between patients with and without confirmed COVID-19 as the underlying primary contributory cause, stratified according to sex, and age band (18-29, 30- per 100,000 population for non-COVID deaths. The absolute number of COVID-19 deaths was higher for men than women throughout the study period (Figure 1) , with peak mortality observed between the 4 th and 20 th April 2020. Figure 2 ) A similar pattern was observed in the non-COVID group, albeit with less pronounced sex differences in ASMR. Overall, the most common cause of death in younger age groups (<60 years) was cancer, whereas the most common causes of death in older age groups (>80 years) were dementia, cancer and old age ( Figure S1 ) Approximately a third of individuals had no underlying chronic conditions in the non-COVID (29.9%) and COVID groups (31.8%), and close to one in ten patients with COVID-19 and non-COVID-19 deaths had three or more underlying conditions (10.4% vs. 9%). ( for all). There was no difference in the rates of underlying cancer, liver disease, pulmonary embolism and valvular heart disease between sexes. While this pattern was generally consistent across the age groups, the rates of certain underlying conditions were higher for the younger age bands (Table S3A and S3B, Figure 4 ) Pulmonary embolism was more frequently reported in <60 and 60-69 age deciles, more so in men than women (<60 years: England and Wales, is the first to demonstrate that the age standardized mortality rate of COVID is significantly higher than that of any other primary cause of death in non-COVID subjects throughout the same period. This finding was consistent across all age groups and in both sexes, with the exception of women between 30-79 years whose mortality from cancer was comparable to that from COVID. Our findings suggest that age-standardized mortality in men was almost double compared to that of women across all age groups, despite crude death rates suggesting a significantly higher proportion of women ≥90 years dying from COVID-19 compared with men. Our crude findings are consistent with reports in the US, which show 41.7% of female deaths were amongst those 85 years and older compared to only 23.9% in men, with higher mortality in younger male age groups compared to women. 17 Similarly, data on COVIDrelated deaths in Italy (n=31,096) demonstrates higher mortality in men than women across all age deciles except ≥90 years where mortality was higher than in women. 16 However, neither analyses provided an adjustment for age, which makes comparisons between sexes challenging. Differences in outcomes between sexes could be explained by the greater number of reported underlying conditions in men compared to women as demonstrated in our analysis. Another proposed hypothesis relates to the circulating level of angiotensin-converting enzyme 2 (ACE2), the main host cell receptor towards which SARS-CoV-2 has been shown to have significantly high affinity, which has been shown to be greater in men than women, and in adults compared to children. 28 5, 29 Furthermore, women are believed to have a better immune response against viral infections compared with men, primarily due to higher levels of estrogen, which is also believed to directly suppress viral replication. 7, 8, 13 The decline in levels of estrogen with advanced age, albeit with higher level in females throughout, could also explain the higher rate of mortality elder subjects. 6 Our analysis suggests that a small proportion of COVID-19 deaths experienced acute events such ACS, acute stroke and pulmonary embolism, and these were lower than in non-COVID deaths. It is difficult to compare these findings to other studies due to limited data on the acute conditions reported in COVID deaths from other countries, or whether there may have been an element of reporting bias, where acute events were reported as COVID deaths. Previous studies have suggested a high prevalence of certain comorbidities such as hypertension and ischemic heart disease in patients who died from COVID-19. 20 24, 25 30 However, these have been mostly limited by their small sample size or analysis of selected cohorts (e.g. intensive care admission only). In our analysis we find that a third of individuals who died had no underlying chronic conditions, but there were more chronic conditions in COVID than non-COVID deaths, with the most prevalent reported being hypertension, dementia, chronic lung disease and diabetes in both groups. Interestingly, we find that the prevalence of ischemic heart disease in COVID-19 related deaths is similar to that observed in non COVID-19 deaths, apart from in younger men (<60 years old) where paradoxically the prevalence is double that in patients that died non-COVID deaths. Reports from several studies have demonstrated a high prevalence of cardiovascular disease (CVD) in patients with COVID-19. 25 24 31 Although the underlying mechanisms are unclear, patients with CVD are more likely to develop severe COVIDinfection, which is attributed to multiple factors including advanced age, lower ACE2 levels and impaired immunity. 32 It is also possible that pharmacological treatment administered for COVID infection provokes fatal arrhythmias, to which CVD patients appear to be more susceptible. 33 In a meta-analysis of 1576 COVID-infected patients, the most prevalent comorbidities were hypertension (21.1%), diabetes (9.7%) and CVD (8.4%). Their analysis showed that the odds ratios (OR) of hypertension and CVD were significantly higher in patients with severe than non-severe COVID (OR 2.36 (95% confidence interval (CI): 1.46-3.83) and 3.42 (95% CI: 1.88-6.22), respectively). 34 However, these data may not hold true in patients who die from COVID, who may have greater baseline comorbidity. In a report from the Italian Instituto Superiore Di Sanita the prevalence of hypertension (68.3%) and ischemic heart disease (28.3%) was significantly higher in COVID deaths (n=31.096). 35 Differences between countries may reflect differences in reporting methods, or sociodemographic and genetic differences. Amongst COVID deaths, acute conditions were observed to be either similar between sexes (pulmonary embolism) or more prevalent in men (ACS and acute stroke). In terms of chronic conditions, women had higher rates of dementia, heart failure and chronic lung disease compared to men, whilst men had higher rates of pre-existing IHD, CKD, hypertension and diabetes. Notably, there was no difference in the rates of underlying cancer between sexes. Although the pattern of findings was consistent across age groups, certain differences in underlying conditions were noted. Pulmonary embolism was more frequently reported in <60 and 60-69 age deciles amongst COVID deaths, more so in men than women, whereas cancer rates were higher in younger age groups, especially in women compared to men. Data on 31.096 COVID deaths from Italy shows that men had a higher prevalence of IHD (31.7% vs. 21.3%), diabetes (30.8% vs. 28.8%) and chronic renal failure (21.5% vs. 18.2%) and lower prevalence of heart failure (14.6% vs. 18.1%), compared to women, and that there was no difference in the rates of active cancer between sexes (men: 15.9% vs. women: 15.6%), all of which are in line with our findings. 35 However, their report did not compare these conditions between age groups. The present findings have several important implications from a national and international perspective. Our comprehensive analysis adds to the body of literature on sex and age differences in patterns of death from a national perspective in a population with a high mortality rank. Furthermore, our report of underlying medical conditions in the overall population of COVID-19 deaths, as well as in both sexes, may help inform stakeholders' and governments' policies by identifying high-risk groups who could benefit from prolonged shielding, especially in the event of a second peak, and/or vaccination priority in the future. Although our study provides insights into the patterns of age and sex differences in COVID-19-related deaths and reported underlying medical conditions in a full nationwide cohort from England and Wales, there are a number of limitations. First, only conditions that were thought to contribute to the death are entered on the death certificate, rather than a list of all comorbid conditions that a patient may have. Our analysis therefore provides an overview of comorbid conditions that were judged by clinicians completing the death certificate to have contributed to death, without any external auditing, rather than a description of all prevalent comorbid conditions. Second, we did not have access to ethnic data, that may confound our analyses, particularly given that the mortality rate from COVID-19 in Black, Asian and minority ethnic people have been reported as up to three times greater. 36 In this nationwide analysis of deaths in England and Wales between 1 st March and 12 th May 2020, we demonstrate that the age-adjusted mortality of COVID-19 was higher than that of other primary causes of death across all age groups and in both sexes, with the exception of cancer mortality in women between 30-79 years, whose adjusted-mortality was higher than COVID-19. Our findings also suggest persistently higher age-adjusted mortality in men compared to women across all age groups throughout the study period. Our report of underlying medical conditions in the overall population of COVID-19 deaths, as well as in both sexes, may help inform stakeholders' and government body policies by identifying highrisk groups. COVID-19) in the UK The gendered dimensions of COVID-19 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19) Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health Severe acute respiratory syndrome (SARS) in neonates and children Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Sex Differences in COVID-19 Case Fatality Rate: Insights From a Multinational Registry Methods for estimating the case fatality ratio for a novel, emerging infectious disease Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus Disease 2019 (COVID-19) in Italy SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region COVID-19 and the cardiovascular system COVID-19 and Cardiovascular Disease Arrhythmias and sudden cardiac death in the COVID-19 pandemic Running title: Underlying conditions in COVID-19 deaths MRCP(UK) 1,2 , Chris P. Gale, PhD FRCP 3,4 Institutes of Applied Clinical Science and Primary Care and Health Sciences Division of Informatics, Imaging and Data Science References: 1. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)2020. 2. (ONS) OfNS. Coronavirus (COVID-19) roundup2020 COVID-19) in the UK The gendered dimensions of COVID-19 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19) Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection Sex Drives Dimorphic Immune Responses to Viral Infections Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study Demographic science aids in understanding the spread and fatality rates of COVID-19 Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health Severe acute respiratory syndrome (SARS) in neonates and children Characteristics of COVID-19 patients dying in Italy: Istituto Superiore di Sanità; 2020. 17. (NCHS) NCfHS. Provisional COVID-19 Death Counts by Sex Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Sex Differences in COVID-19 Case Fatality Rate: Insights From a Multinational Registry Methods for estimating the case fatality ratio for a novel, emerging infectious disease Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus Disease 2019 (COVID-19) in Italy SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region COVID-19 and the cardiovascular system COVID-19 and Cardiovascular Disease Arrhythmias and sudden cardiac death in the COVID-19 pandemic Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Characteristics of COVID-19 patients dying in Italy: Istituto Superiore di Sanità; 2020. 36. (ONS) OfNS. Coronavirus (COVID-19) related deaths by ethnic group We thank Mr. Ben Humberstone and colleagues from the Office for National Statistics for their assistance in accessing and interpreting the death registration data. We thank Mr. Ben Humberstone and colleagues from the Office for National Statistics for their assistance in accessing and interpreting the death registration data.